Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack
Public ClinicalTrials.gov record NCT01539590. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to Percutaneous Coronary Intervention (PCI) in Subjects Presenting With Acute ST Segment Elevation Myocardial Infarction (STEMI)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study will evaluate the effect of BB3 to preserve myocardial (heart) tissue and function following myocardial infarction (heart attack).
Study identification
- NCT ID
- NCT01539590
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 5 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2012
- Primary completion
- Jun 30, 2013
- Completion
- Oct 31, 2013
- Last update posted
- Nov 20, 2014
2012 – 2013
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Minneapolis Heart Institute Foundation | Minneapolis | Minnesota | 55417-1139 | — |
| Yale University Medical Center | New Haven | New York | 06520 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Myocardial Infarction trials
Other public records listing Myocardial Infarction. Sorted by last update posted; newest first. Not a recommendation.
- NCT05925634: Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial Active, not recruiting
- NCT04521699: Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk. Recruiting
- NCT07541014: TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary Syndrome Recruiting
- NCT06593418: Cardiac Radioablation for VT Not yet recruiting
- NCT03022552: Heart Attack Research Program: Platelet Sub-Study (HARP) Recruiting
- NCT06271577: Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01539590, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2014 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01539590 live on ClinicalTrials.gov.